We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$225B
1-Year Est. Return
49.49%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+49.49%
3 Year Est. Return
+172.58%
5 Year Est. Return
+223.9%
10 Year Est. Return
+876%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Grand Canyon Education
LOPE
$3.79B
| $534K | ﹤0.01% |
+5,057
| New | +$504K |
|
1127
Mohawk Industries
MHK
$9.42B
| $533K | ﹤0.01% |
+5,215
| New | +$511K |
|
1128
Porch Group
PRCH
$1.92B
| $521K | ﹤0.01% |
+276,986
| New | +$489K |
|
1129
First Hawaiian
FHB
$3.39B
| $518K | ﹤0.01% |
+19,878
| New | +$510K |
|
1130
Oportun Financial
OPRT
$351M
| $509K | ﹤0.01% |
+92,291
| New | +$483K |
|
1131
Evertec
EVTC
$1.91B
| $502K | ﹤0.01% |
15,494
-4,339
| -22% | -$143K |
|
1132
Vitamin Cottage Natural Grocers
NGVC
$646M
| $499K | ﹤0.01% |
54,590
+40,239
| +280% | +$423K |
|
1133
Scotiabank
BNS
$111B
| $491K | ﹤0.01% |
10,024
-310,426
| -97% | -$15.3M |
|
1134
Integer Holdings
ITGR
$4.25B
| $487K | ﹤0.01% |
7,120
-47,683
| -87% | -$3.12M |
|
1135
Plexus
PLXS
$7.04B
| $485K | ﹤0.01% |
+4,711
| New | +$476K |
|
1136
Consensus Cloud Solutions
CCSI
$717M
| $480K | ﹤0.01% |
8,923
-4,586
| -34% | -$250K |
|
1137
J.M. Smucker
SJM
$12.9B
| $475K | ﹤0.01% |
+3,000
| New | +$447K |
|
1138
Valhi
VHI
$466M
| $474K | ﹤0.01% |
21,559
-396
| -2% | -$9.62K |
|
|
BELFB
1139
Bel Fuse Inc Class B
BELFB
$4.13B
| $468K | ﹤0.01% |
14,219
-15,496
| -52% | -$506K |
|
1140
Corcept Therapeutics
CORT
$11.9B
| $468K | ﹤0.01% |
+23,048
| New | +$578K |
|
|
ARC
1141
DELISTED
ARC Document Solutions, Inc.
ARC
| $468K | ﹤0.01% |
159,817
| – | – |
|
|
SEM
1142
DELISTED
Select Medical
SEM
| $467K | ﹤0.01% |
+34,885
| New | +$451K |
|
1143
Sensus Healthcare
SRTS
$52M
| $467K | ﹤0.01% |
62,928
-33,991
| -35% | -$307K |
|
1144
eGain
EGAN
$206M
| $466K | ﹤0.01% |
51,603
| – | – |
|
1145
Mayville Engineering Co
MEC
$597M
| $463K | ﹤0.01% |
+36,567
| New | +$365K |
|
1146
Dr. Reddy's Laboratories
RDY
$10.3B
| $456K | ﹤0.01% |
44,025
-7,235
| -14% | -$78.1K |
|
1147
Merit Medical Systems
MMSI
$5.4B
| $454K | ﹤0.01% |
+6,431
| New | +$429K |
|
1148
Rush Enterprises Class A
RUSHA
$9.62B
| $453K | ﹤0.01% |
12,990
-44,550
| -77% | -$1.48M |
|
1149
RB Global
RBA
$16B
| $451K | ﹤0.01% |
+7,818
| New | +$455K |
|
1150
Consumer Portfolio Services
CPSS
$208M
| $443K | ﹤0.01% |
50,052
+27,034
| +117% | +$194K |
|
Similar funds
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.